Medicine and Dentistry
Subarachnoid Hemorrhage
36%
Brain Ischemia
34%
Extracorporeal Membrane Oxygenation
34%
Intensive Care Unit
30%
Apoplexy
21%
Extracorporeal Life Support
18%
Hematologic Malignancy
15%
Heart Arrest
14%
Heart Surgery
13%
Cohort Analysis
12%
Intensive Care
12%
Observational Study
12%
Status Epilepticus
12%
Cohort Study
11%
Anticoagulation
9%
Myoclonus
9%
Artificial Respiration
9%
Health Care Cost
8%
Bleeding
8%
Clinical Trial
8%
Thromboembolism
7%
Cerebral Hemorrhage
7%
Quality of Life
7%
Platelet
7%
Randomized Controlled Trial
7%
APACHE II
7%
Retrospective Cohort Study
6%
Magnesium
6%
Hospital Cost
6%
near Infrared Spectroscopy
6%
Thorax Surgery
6%
Thrombocyte Transfusion
6%
Thrombocytopenia
6%
Cardiopulmonary Bypass
6%
Erythrocyte
6%
Hazard Ratio
6%
Drug Therapy
5%
Resuscitation
5%
Partial Thromboplastin Time
5%
Odds Ratio
5%
Aneurysm
5%
Keyphrases
Aneurysmal Subarachnoid Hemorrhage (aSAH)
49%
Delayed Cerebral Ischemia
41%
Poor Outcome
23%
Subarachnoid Hemorrhage
23%
Magnesium Treatment
20%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
16%
Magnesium
15%
Intensive Care Unit
13%
Cardiac Surgery
10%
Randomized Clinical Trial
9%
Confidence Interval
8%
Clinical Trials
7%
Observational Cohort Study
6%
Induced Hypertension
6%
Intensive Care Unit Patients
6%
Transfusion
6%
Magnesium Sulfate
6%
Anticoagulation
6%
Glucose Level
6%
Hemorrhagic Complications
6%
Spreading Depolarization
6%
Post-hypoxic Myoclonus
6%
Red Blood Cells
6%
Platelet Transfusion
6%
Thrombocytopenia
6%
Drug Interactions
6%
Cardiopulmonary Bypass
6%
1-year Mortality
6%
Extracorporeal Life Support
6%
Beneficial Effects
5%
Myoclonus
5%
Cardiac Arrest
5%
Pharmacology, Toxicology and Pharmaceutical Science
Subarachnoid Hemorrhage
100%
Brain Ischemia
56%
Randomized Clinical Trial
12%
Magnesium Sulfate
12%
Aneurysm
10%
Placebo
9%
Cohort Study
9%
Epileptic State
9%
Heart Arrest
7%
Clinical Trial
7%
Randomized Controlled Trial
6%
Drug-Drug Interaction
6%
Acetylsalicylic Acid
6%
Hydrocephalus
6%
Thromboembolism
6%
HIV
6%
Neuroprotective Agent
5%
Ischemia
5%
Neuroprotection
5%
Brain Infarction
5%
Observational Study
5%